ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | +50.0% | 1,666 | 0.0% | 0.01% | +37.5% |
| Q2 2022 | $8,000 | -11.1% | 1,666 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $9,000 | -10.0% | 1,666 | 0.0% | 0.01% | -11.1% |
| Q4 2021 | $10,000 | -33.3% | 1,666 | 0.0% | 0.01% | -30.8% |
| Q3 2021 | $15,000 | +15.4% | 1,666 | 0.0% | 0.01% | +18.2% |
| Q2 2021 | $13,000 | – | 1,666 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Interchange Capital Partners, LLC | 11,420 | $90,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 47,097 | $373,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $80,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 99,166 | $784,000 | 0.01% |
| EMFO, LLC | 1,666 | $13,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 34,333 | $272,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 51,466 | $407,000 | 0.00% |
| Tarbox Family Office, Inc. | 332 | $3,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,808 | $30,000 | 0.00% |